These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Safety experience with heptavalent pneumococcal CRM197-conjugate vaccine (Prevenar) since vaccine introduction. Center KJ; Strauss A Vaccine; 2009 May; 27(25-26):3281-4. PubMed ID: 19200818 [TBL] [Abstract][Full Text] [Related]
4. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk]. de Greeff SC; Sanders EA; de Melker HE; van der Ende A; Vermeer PE; Schouls LM Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1454-7. PubMed ID: 17633974 [TBL] [Abstract][Full Text] [Related]
6. Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Sever JL; Brenner AI; Gale AD; Lyle JM; Moulton LH; West DJ; Pharmacoepidemiol Drug Saf; 2002; 11(3):189-202. PubMed ID: 12051118 [TBL] [Abstract][Full Text] [Related]
7. Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Sever JL; Brenner AI; Gale AD; Lyle JM; Moulton LH; Ward BJ; West DJ Pharmacoepidemiol Drug Saf; 2004 Dec; 13(12):825-40. PubMed ID: 15386719 [TBL] [Abstract][Full Text] [Related]
8. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines. Chevallier B; Vesikari T; Brzostek J; Knuf M; Bermal N; Aristegui J; Borys D; Cleerbout J; Lommel P; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S109-18. PubMed ID: 19325447 [TBL] [Abstract][Full Text] [Related]
9. Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013. Miller ER; Moro PL; Cano M; Lewis P; Bryant-Genevier M; Shimabukuro TT Vaccine; 2016 May; 34(25):2841-6. PubMed ID: 27087150 [TBL] [Abstract][Full Text] [Related]
11. The Intensive Vaccines Monitoring Programme (IVMP): an electronic system to monitor vaccine safety in New Zealand. Tatley MV; Kunac DL; McNicholas A; Zhou L; Ballantyne S; Ashton J; Stehr-Green P; Galloway Y; Reid S Vaccine; 2008 May; 26(22):2746-52. PubMed ID: 18430496 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of pneumococcal 7-valent conjugate vaccine (diphtheria CRM(197) protein conjugate; Prevenar ) in Korean infants: differences that are found in Asian children. Kim NH; Lee J; Lee SJ; Lee H; Kim KH; Park SE; Lee HJ Vaccine; 2007 Nov; 25(45):7858-65. PubMed ID: 17931753 [TBL] [Abstract][Full Text] [Related]
13. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands. David S; Vermeer-de Bondt PE; van der Maas NA Vaccine; 2008 Oct; 26(46):5883-7. PubMed ID: 18775463 [TBL] [Abstract][Full Text] [Related]
14. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use. Knopp MV; Balzer T; Esser M; Kashanian FK; Paul P; Niendorf HP Invest Radiol; 2006 Jun; 41(6):491-9. PubMed ID: 16763467 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206 [TBL] [Abstract][Full Text] [Related]
16. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk]. van der Harst S Ned Tijdschr Geneeskd; 2007 Aug; 151(33):1853-4; author reply 1854. PubMed ID: 17874645 [No Abstract] [Full Text] [Related]
17. Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine. Smets F; Bourgois A; Vermylen C; Brichard B; Slacmuylders P; Leyman S; Sokal E Vaccine; 2007 Jul; 25(29):5278-82. PubMed ID: 17576024 [TBL] [Abstract][Full Text] [Related]
18. Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005. Dobardzic A; Izurieta H; Woo EJ; Iskander J; Shadomy S; Rupprecht C; Ball R; Braun MM Vaccine; 2007 May; 25(21):4244-51. PubMed ID: 17382435 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous vaccination of Chinese applicants for a United States immigrant visa. Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068 [TBL] [Abstract][Full Text] [Related]
20. Highlights of the 22nd French pharmacovigilance meeting. Prescrire Int; 2002 Feb; 11(57):21-3. PubMed ID: 11985373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]